HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 627052Generated: October 30, 2026
Diisopropylethylamine → tert-butyl (1R)-2-(2-(2,6-difluorophenylcarbamoyl)-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-1-yl)-2-oxo-1-(tetrahydro-2 h-pyran-4-yl)ethylcarbamate
https://huagongshe.com/reaction/627052

Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | Tetramethylfluoroformamidinium hexafluorophosphate | HCID 2774761 | — |
| Reactant | (S)-2-((tert-Butoxycarbonyl)amino)-2-(tetrahydro-2H-pyran-4-yl)acetic acid | HCID 25260122 | — |
| Reactant | N-(2,6-difluorophenyl)-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine-2-carboxamide | HCID 117872809 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | tert-butyl (1R)-2-(2-(2,6-difluorophenylcarbamoyl)-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-1-yl)-2-oxo-1-(tetrahydro-2 h-pyran-4-yl)ethylcarbamate | HCID 131735268 | — |
| Product | tert-butyl (1S)-2-(2-(2,6-difluorophenylcarbamoyl)-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-1-yl)-2-oxo-1-(tetrahydro-2 h-pyran-4-yl)ethylcarbamate | HCID 131735269 | — |
Reaction Steps
To a solution of (S)-2-(tert-butoxycarbonylamino)-2-(tetrahydro-2 h-pyran-4-yl)acetic acid (94.2 mg, 363 μmol, Eq: 2) and diisopropylethylamine (127 μL, 727 μmol, Eq: 4) in DCM (2 mL) was added N,N,N′,N′-tetramethylfluoroformamidinium hexafluorophosphate (115 mg, 436 μmol, Eq: 2.4) and the resulting solution was stirred at rt for 1 h. N-(2,6-difluorophenyl)-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine-2-carboxamide (50 mg, 182 μmol, Eq: 1.00) was added and the reaction was stirred at rt overnight. The reaction mixture was diluted with EtOAc (20 mL) and washed with 0.1 M aqueous KHSO4, 0.1 M aqueous NaOH and brine and concentrated in vacuo. The crude material was purified by flash chromatography (silica gel, 12 g, 0% to 50% EtOAc in hexanes) to give tert-butyl (1R)-2-(2-(2,6-difluorophenylcarbamoyl)-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-1-yl)-2-oxo-1-(tetrahydro-2 h-pyran-4-yl)ethylcarbamate (48 mg) and tert-butyl (1S)-2-(2-(2,6-difluorophenylcarbamoyl)-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-1-yl)-2-oxo-1-(tetrahydro-2 h-pyran-4-yl)ethylcarbamate (46 mg), m/z=517 (M+H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09309248B2 |
|---|
| Source dataset | uspto-grants-2016_04 |
|---|
| ORD ID | ord-7e2f6f363de54ae5bc53873988974a8f |
|---|
| Source note | uspto-grants-2016_04 |
|---|